These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8585911)

  • 21. Age at renal replacement therapy in autosomal dominant polycystic kidney disease.
    Gonzalo A; Gallego A; Tato A; Ortuño J
    Nephron; 1996; 74(3):620. PubMed ID: 8938693
    [No Abstract]   [Full Text] [Related]  

  • 22. The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration.
    Hommel K; Rasmussen S; Madsen M; Kamper AL
    Nephrol Dial Transplant; 2010 Mar; 25(3):947-51. PubMed ID: 19861312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticipation of end-stage renal disease in autosomal dominant polycystic kidney disease.
    Gonzalo A; Gallego A; San Millan JL; Ortuño J
    Nephrol Dial Transplant; 1996; 11 Suppl 6():21-3. PubMed ID: 9044323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical problems in hemodialysis patients with autosomal dominant polycystic kidney disease.
    Kocyigit I; Eroglu E; Gungor O
    Semin Dial; 2018 May; 31(3):268-277. PubMed ID: 29664556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal dominant polycystic kidney disease--clinical challenges.
    Fields A; Richards T; Frost E; Kaye AD
    Middle East J Anaesthesiol; 2003 Jun; 17(2):205-18. PubMed ID: 14503122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of renal transplantation in polycystic kidney disease.
    Stiasny B; Ziebell D; Graf S; Hauser IA; Schulze BD
    Clin Nephrol; 2002 Jul; 58(1):16-24. PubMed ID: 12141402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttransplant Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Versus Other Recipients: A 10-Year Report From South of Iran.
    Roozbeh J; Malekmakan L; Harifi MM; Tadayon T
    Exp Clin Transplant; 2018 Dec; 16(6):676-681. PubMed ID: 27759554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.
    Lee VW; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):595-602.e12. PubMed ID: 26718164
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical features and outcome of ADPKD patients after renal transplantation.
    Salvadori M; Bandini S; Bertoni E; Piperno R; Rosati A; Tosi P
    Contrib Nephrol; 1995; 115():141-3. PubMed ID: 8585902
    [No Abstract]   [Full Text] [Related]  

  • 30. Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia.
    Comas J; Arcos E; Castell C; Cases A; Martínez-Castelao A; Doñate T; Esmatjes E
    Nephrol Dial Transplant; 2013 May; 28(5):1191-8. PubMed ID: 23147160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal dominant polycystic kidney disease.
    Torres VE; Harris PC; Pirson Y
    Lancet; 2007 Apr; 369(9569):1287-1301. PubMed ID: 17434405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
    Batista PB; Lopes AA; Costa FA
    Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful pregnancy in a patient with polycystic kidney disease and advanced renal failure: the use of prophylactic dialysis.
    Alcalay M; Blau A; Barkai G; Lipitz S; Mashiach S; Eliahou HE
    Am J Kidney Dis; 1992 Apr; 19(4):382-4. PubMed ID: 1562030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autosomal dominant polycystic kidney disease: light at the end of the tunnel?].
    Melander C; Joly D; Knebelmann B
    Nephrol Ther; 2010 Jul; 6(4):226-31. PubMed ID: 20430712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
    Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A
    Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urological procedures for progressive renal dysfunction due to polycystic kidney disease].
    Nakatani T; Kishimoto T; Tsujino T; Sugimura T; Oyama A; Kato T; Higashihara E
    Hinyokika Kiyo; 2000 Sep; 46(9):645-50. PubMed ID: 11107537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic renal failure in a patient with Sotos syndrome due to autosomal dominant polycystic kidney disease.
    Cefle K; Yildiz A; Palanduz S; Ozturk S; Ozbey N; Kylyçaslan I; Colakoglu S; Balci C
    Int J Clin Pract; 2002 May; 56(4):316-8. PubMed ID: 12074220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal failure in a patient with autosomal dominant polycystic kidney disease and coexisting dermato-polymyositis: first report in the literature.
    Bahceci F; Sari R; Sarikaya M; Atik E; Karincaoglu Y; Sevinc A
    J Natl Med Assoc; 2004 Jun; 96(6):844-6. PubMed ID: 15233496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute abdomen in a haemodialysed patient with polycystic kidney disease--rupture of a massive liver cyst.
    Chung TK; Chen KS; Yen CL; Chen HY; Cherng WJ; Fang KM
    Nephrol Dial Transplant; 1998 Jul; 13(7):1840-2. PubMed ID: 9681743
    [No Abstract]   [Full Text] [Related]  

  • 40. Shape of the relationship between hypertension and the rate of progression of renal failure in autosomal dominant polycystic kidney disease.
    Gonzalo A; Gallego A; Rivera M; Orte L; Ortuño J
    Nephron; 1992; 62(1):52-7. PubMed ID: 1436292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.